# ClaimGlide: Prior-auth work that ends with evidence in the EMR

Canonical: https://mudpie.ai/companies/claimglide/
Breadcrumb: [Home](https://mudpie.ai/) / [Companies](https://mudpie.ai/companies/) / [ClaimGlide: Prior-auth work that ends with evidence in the EMR](https://mudpie.ai/companies/claimglide/)
Author: Ali Abouelatta (https://mudpie.ai/authors/ali-abouelatta/)
Published: 2026-09-19
Updated: 2026-09-19
Research type: Company profile
Method: Company and accelerator sources checked 2026-09-19. Product claims are attributed to their sources; this is research, not a hands-on product trial.

ClaimGlide automates prior authorizations for specialty medical practices. It fits a practice that loses staff time and revenue to payer forms, follow-up, denials and evidence scattered across the EMR and phone calls.

## What it does

[ClaimGlide’s current site](https://claimglide.com/) covers the full prior-authorization loop: create and submit requests, pull provider, patient and diagnosis codes from an EMR, track payer timelines, follow up on delays, generate appeals and store approval evidence. It says the system can handle payer phone calls for an appeal and update the practice-management system with confirmation numbers and documents.

The buyer-facing advantage is completion, not just drafting. A practice can ask whether each authorization is moving, what the payer still needs and where the final evidence lives. The current site lists eClinicalWorks, athenahealth, NextGen Healthcare and ModMed integrations. That is a useful starting point, but the practice should verify which fields, specialties and payer workflows are supported before treating “end to end” as universal.

ClaimGlide’s [YC profile](https://www.ycombinator.com/companies/claimglide) says it automates prior authorizations for private practices and aims to improve acceptance rate and speed. Those are company goals and positioning claims, not independent approval or revenue measurements. The homepage also says the product is HIPAA-compliant; a healthcare buyer should ask for the relevant agreement, controls and scope rather than relying on the badge alone.

## Founder context and tradeoffs

The YC record identifies Nami Lindquist as founder and CEO and describes a Penn M&T background. The company is one-person on the retained profile, which makes the narrow workflow focus understandable and makes support, escalation and payer-coverage questions especially important.

Pricing is not public; the current path is a custom demo. A practice should ask who reviews generated requests, how payer-specific language is updated, how denials are tracked and what happens when an authorization requires clinical judgment. Automation can remove repetitive work without becoming the decision-maker.

## Editorial take

I would shortlist ClaimGlide for a specialty practice with enough prior-auth volume to measure turnaround and denial friction. The right test is one procedure family, one EMR and a complete request-to-approval evidence trail. If the practice has few authorizations or highly bespoke clinical review, the integration cost may not pay back.

## Quick facts

| Field | Sourced detail |
| --- | --- |
| Product | Prior-auth creation, submission, follow-up, appeals and evidence storage |
| Buyers | Specialty private medical practices |
| Integrations | eClinicalWorks, athenahealth, NextGen Healthcare and ModMed listed |
| Pricing | Custom demo; no numeric price observed |
| Main gate | Payer/specialty coverage, EMR fields, clinical review and HIPAA scope |

## Sources checked

| Source | Checked |
| --- | --- |
| [YC profile](https://www.ycombinator.com/companies/claimglide) | 2026-09-19 |
| [ClaimGlide homepage](https://claimglide.com/) | 2026-09-19 |

## Cohort context

ClaimGlide is listed in Winter 2026. In our 2026-09-18 directory snapshot, 16 of 199 listed companies in that cohort have YC’s primary industry label Healthcare (8.0%). This is a current-directory comparison, not an original intake count or a performance ranking. [Nine-cohort dataset](https://mudpie.ai/research/yc-cohorts-2026-09-19.json).

## Public website snapshot

Observed 2026-09-19T16:20:07.157Z in raw homepage HTML. This records visible metadata and advertised links, not agent execution or product quality.

| Signal | Homepage observation |
| --- | --- |
| Product description metadata | Observed |
| Canonical link | Not observed in this response |
| H1 or H2 heading | Observed |
| Typed structured data | Not observed in this response |
| Docs/developer link | Not observed in this response |
| Pricing link | Not observed in this response |
| llms.txt link | Not observed in this response |
| Markdown alternate | Not observed in this response |

[Public observations](https://mudpie.ai/research/yc-homepage-links-2026-09-19.json) · [Collection method](https://mudpie.ai/research/yc-homepage-methods/README.md). Missing links here do not establish that a capability or file is absent elsewhere.


## Author disclosure

I cofound Lazyweb and publish Mudpie. This is an owner-written publication, not an independent testing organization. Research notes distinguish observations, sourced reporting and editorial judgment.